Evgen Pharma plc (EVG) Ordinary 0.25p
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
9.85p
10.00p
16.83p
£13.53 million
9.85p
9.41p
2.75p
n/a
0.35p (3.43%) Previous:
0.35p
166,338
n/a
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/03/2020 | 31/03/2019 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (3.17) | (3.12) |
| Adjusted EPS (p): | (2.10) | (2.74) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
Evgen announces positive preclinical data for SFX-01
22 January 2021 12:01
-
Evgen reports 'highly positive' data from SFX-01 trial
21 January 2021 13:53
-
Evgen Pharma makes progress with 'STAR' trial recruitment
19 January 2021 15:44
-
Preclinical data on a new therapeutic target
22 January 2021 07:00
-
Positive pre-clinical data for lead asset SFX-01
21 January 2021 07:00
-
Patient recruitment update in STAR-COVID 19 trial
19 January 2021 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.